SCHEMBL2807668

SCHEMBL2807668

CC(=O)CCC(=O)O[C@H]1[C@@H]2OC(C)(C)OC[C@H]2OC[C@@]1(O)NC(=O)C(Cl)(Cl)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3640773 0.71 — —
SCHEMBL2802553 0.68 — —
SCHEMBL2802558 0.67 — —
SCHEMBL2803934 0.66 — —
SCHEMBL8818292 0.60 ALDH1A1 (0.42) —
SCHEMBL2672023 0.58 CA2 (0.60) —
SCHEMBL26838502 0.58 CA2 (0.33) —
SCHEMBL1514211 0.57 CA2 (0.49) —
SCHEMBL13218894 0.57 BCHE (0.47) —
SCHEMBL9106316 0.56 NAAA (0.33) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815239-B2 Glycoconjugates and use thereof as vaccine against Shigella flexneri serotype 3a and X INSTITUT PASTEUR (FR) 2014-08-26 — — US disclosed
US-20100239584-A1 GLYCOCONJUGATES AND USE THEREOF AS VACCINE AGAINST SHIGELLA FLEXNERI SEROTYPE 3A AND X INSTITUT PASTEUR (FR) 2010-09-23 — — US disclosed
Send feedback